PA5-59835

antibody from Invitrogen Antibodies

Targeting: BFSP1 CP115, CP94, filensin, LIFL-H

Immunocytochemistry (Supportive data in Antibodypedia)

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

PA5-59835

Provider

Invitrogen Antibodies

Product name

Filensin Polyclonal Antibody

Antibody type

Polyclonal

Antigen

Recombinant full-length protein

Description

Immunogen sequence: ESESKFESES KEVSPLTQEG APEDVPDGGQ ISKGFGKLYR KVKEKVRSPK EPETPTELYT KERHVLVTGD ANYVDPRFYV SSITAKGGVA VSVAEDSVLY DG Highest antigen sequence identity to the following orthologs: Mouse - 59%, Rat - 58%.

Reactivity

Human

Host

Rabbit

Isotype

IgG

Vial size

100 µL

Concentration

0.4 mg/mL

Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Immunocytochemistry

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunofluorescent staining of Filensin in human cell line U-2 OS shows positivity in plasma membrane & cytoplasm. Samples were probed using a Filensin Polyclonal Antibody (Product # PA5-59835).

Immunohistochemistry

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunohistochemical staining of Filensin in human testis using Filensin Polyclonal Antibody (Product # PA5-59835).

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunohistochemical staining of Filensin in human lymph node using Filensin Polyclonal Antibody (Product # PA5-59835).

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunohistochemical staining of Filensin in human kidney using Filensin Polyclonal Antibody (Product # PA5-59835).

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunohistochemical staining of Filensin in human eye using Filensin Polyclonal Antibody (Product # PA5-59835).